Thursday, October 28, 2021
68.6 F
Fort Worth

Search for a cure

🕐 1 min read

Regeneron Pharmaceuticals shares leaped to their highest price in nearly three years after the biotechnology company said it could begin human studies on a treatment for the new coronavirus by early summer. The Tarrytown, New York-based company said its researchers had identified hundreds of virus-neutralizing antibodies and would select the top two to initiate large-scale manufacturing by mid-April with an antibody cocktail therapy. Regeneron said it had used the same technology in the past to develop a successful treatment for the Ebola virus. The company said it aims to produce “hundreds of thousands of prophylactic doses per month by the end of summer, and hopes to have smaller quantities available for initial clinical testing at the beginning of the summer.” Regeneron shares jumped 12% to $491.69 on Tuesday.

Related Articles

Our Digital Sponsors

Latest Articles

Texas-Rangers-Welcome
Fort Worth Business Press Logo
This advertisement will close in
00
Months
00
Days
00
Hours
00
Minutes
00
Seconds
seconds..
Click here to continue to Fort Worth Business Press
Texas Rangers
Fort Worth Business Press Logo
This advertisement will close in
00
Months
00
Days
00
Hours
00
Minutes
00
Seconds
seconds..
Click here to continue to Fort Worth Business Press

Not ready to subscribe?

Try a few articles on us.

Enter your email address and we will give you access to three articles a month, to give us a try. You also get an opportunity to receive our newsletter with stories of the day.

This field is for validation purposes and should be left unchanged.

Get our email updates

Stay up-to-date with the issues, companies and people that matter most to business in the Fort Worth.

  • Restaurants
  • Technology
  • and more!

FWBP Morning Brief

FWBP 5@5

Weekend Newsletter

  • Banking & Finance
  • Culture
  • Real Estate